Success Story: NIW Approved Despite RFE! Our Firm Helped a Postdoctoral Researcher Secure Success with Premium Processing Service
Client’s Testimonial:
“Thank you very much for your assistance throughout the NIW process. I truly appreciate your support and am very pleased with the approval.”
On August 20th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Bioengineering (Approval Notice).
General Field: Bioengineering
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: India
State of Residence at the Time of Filing: California
Approval Notice Date: August 20th, 2026
Processing Time: 6 months, 8 days (Premium Processing Requested)
Case Summary:
Improving medical care often depends on technologies that can make testing faster, more accessible, and easier to deploy while giving researchers better ways to understand how individual cells function. These needs shaped the client’s work in bioengineering. With a Ph.D. in bioengineering, the client conducts research on scalable diagnostic and biological screening technologies.
At the time of the petition, the client was conducting research at a U.S. university, where the client planned to continue developing rapid diagnostic tools and technologies for studying biological function at the cellular level. In preparing the client’s I-140 EB-2 National Interest Waiver (NIW) petition, North America Immigration Law Group (Chen Immigration Law Associates) emphasized how this work addressed broader U.S. needs involving diagnostic accessibility, biomedical innovation, and healthcare research. The petition also documented support for the client’s research from the National Science Foundation, helping demonstrate independent federal interest in research directions related to the client’s ongoing work.
Among the credentials presented in support of the petition were:
- 20 peer-reviewed journal articles, including 7 first-authored articles and 1 submitted article
- 1 peer-reviewed conference article
- 26 research abstracts, including 13 first-authored abstracts
- 1 first-authored patent
- 680 citations to the client’s published research
These figures were not presented as sufficient by themselves. Instead, we placed them in context to demonstrate how the client’s work had influenced subsequent research. Multiple publications ranked within highly cited percentiles for their respective fields and publication years, including papers in the top 10%, top 1%, and, in one instance, top 0.01%. This comparative evidence helped show that researchers were engaging with the client’s findings at unusually high rates relative to appropriate benchmarks.
We further documented examples of independent researchers using the client’s work to guide the development and evaluation of diagnostic technologies, laboratory methods, and biological screening approaches. By showing how others incorporated the client’s findings into their own investigations, the petition connected the citation record to concrete scientific influence rather than relying solely on citation totals.
The client filed the I-140 NIW petition with premium processing requested at the time of filing and later received a Request for Evidence (RFE). Following the RFE process, the petition was approved. The approval allowed the client to continue pursuing research aimed at making biomedical technologies more accessible and strengthening tools for disease detection and biological discovery in the United States.